Peter Brian Worrall

Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom.

Union MedTech Plc is engaged in employing a buy and build strategy in the medical device arena. It is seeking to acquire and aggregate a number of proprietary medical device technologies in the areas, like orthopaedic and cardiac devices, as well as in novel areas such as bringing together complementary drug and device technologies. The company is focused on aggregating complementary technologies and adding significant value through clinical advancement, operational synergies and experienced management. The company was founded on November 13, 2007 and is headquartered in London, the United Kingdom.

immersive education Ltd. designs and markets interactive educational software applications. Its products include kar2ouche, a story-boarding and role-playing software; mediastage, a 3D virtual production studio; krucible, a science simulation software; and missionmaker, a game-authoring software tool. The company was founded in 1999 and is headquartered in Oxfordshire, the United Kingdom.

Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown.

I-MED Radiology Network Ltd. engages in the operation of medical imaging clinic network. Its procedures offered include angiography, biopsy, bone density scan, breast core biopsy, cardiac services, CT scan, general x-ray, MRI, transvaginal ultrasound, ultrasound, and weight bearing MRI. The company is headquartered in Sydney, Australia.

Vanguard Group Plc a Uk based company engages in research and development of pharmaceutical products. Its current status is extinct.

Rex Bionics Plc engages in the development and manufacture of hands-free robotic exoskeletons designed to enable a wheelchair user to stand and walk. The company was founded by Richard Little and Robert Irving on November 13, 2007 and is headquartered in Marlow, the United Kingdom.